ABSTRACT
INTRODUCTION
Diabetes mellitus is a major public health problem in the developed as well as developing countries. It is ranked seventh among the leading causes of death, and third when its fatal complications are taken in to account (1) . Traditional antidiabetic plants might provide a useful source of new oral hypoglycemic compounds for development as pharmaceutical entities or as simple dietary adjuncts to existing therapies (2) .
Herbal treatments are becoming increasing by popular as the herbal preparations have no or least side effects (3) . Terminala arjuna is an important medicinal plant widely used in the preparation of Ayurvedic formulations used against several ailments. The use of Terminalia arjuna bark in the management of hypercholesterolaemia has been widely reported (4) (5) (6) (7) (8) (9) . The pharmacological studies have shown antiviral (10) anti mutagenic (11) antiplague formation (I2), anticancer (13) and hypotensive properties (14) and abnormal platelet activity (15) diabetes in human trial (16) , (17) , (18) .
There were no reports on the ability of T.arjuna bark on gluconeogenic and glycolytic enzymes in diabetes. Present investigation aims to study the regulation of carbohydrate metabolic and catabolic enzymes in liver and kidneys of normal and alloxan induced diabetic rats.
MATERIALS AND METHODS Plant material and preparation of 50% ethanolic extract
The wet Terminalia arjuna bark was collected from Siruvani coastel of Agali in Kerala. The specimen was certified by Botanical Survey of India (BSI) Coimbatore, and by the Department of Pharmacognosy and Phytochemistry, J.S.S College of Pharmacy Ooty, Tamil Nadu, India.
Terminalia arjuna was used in the form of crude 50% ethanol extract and this extract was prepared according to the traditional system of medicine. The shade dried and coarsely powdered stem bark (1kg) was extracted with 50% alcohol in the cold for 72 hours. The extract was filtered and distilled on water bath, a reddish brown syrupy mass was obtained and it was finally dried at low temperature under reduced pressure in a rotary evaporator. A crude residue (75g) was obtained giving a yield of 7.5%. The antidiabetic effects were evaluated by oral administration of the extract to the alloxan induced diabetic rats.
Animals
Male albino rats of Wistar strain weighing about 150 -200 g obtained from the Medical College of Trichur (Kerala) were used for the study. They were fed a standard rat pellet diet (Sai Durga feeds, Bangalore) and water was provided adlibitum and maintained under standard laboratory conditions. (Temperature 24-28°C, relative humidity 60 -70%) Animals described as fasted were deprived of food for 16 hours but had free access to water.
Alloxan Induced diabetes
Diabetes was induced by a single ip injection of 120 mg/kg of alloxan monohydrate (S.D Fine -Chem. Ltd., Mumbai, India), in sterile saline (19) . After 72 hours of alloxan injection, the diabetic rats (glucose level > 250 mg/dl) were separated and used for the study (20) .
Experimental set up
The animals were divided in to 6 groups of 6 each. Group I served as normal healthy control. Group II (untreated diabetic control). Group III diabetic rats given T.arjuna bark extract (250 mg/kg body weight). Group IV diabetic rats given T.arjuna bark extract (500 mg/kg body weight). Group V control rats given T.arjuna bark extract (250 mg/kg body weight) Group VI control rats given T.arjuna bark extract (500 mg/kg body weight). The crude extract was administered for a period of 30 days.
Collection of blood, kidney and liver from the rat
After the experimental regimen, the animals were sacrificed by cervical dislocation under mild chloroform anesthesia. Blood was collected on decapitation and serum was separated by centrifugation (for 20 min at 2000 rpm). The liver and kidney were excised immediately and thoroughly washed in ice -cold saline. The serum and tissues were collected and used for biochemical experiments.
Estimation of biochemical parameters
Serum glucose was estimated by GOD/POD method (21), hexokinase (22) , phosphoglucoisomerase (23) , aldolase (24), glucose-6-phosphatase (25) and fructose-1,6-disphosphatase (26) were assayed in liver and kidney.
RESULTS AND DISCUSSION
As shown in (Table 1 ) the levels of glucose in serum of alloxan induced diabetic rats were found to be significantly elevated as compared with control rats. Oral administration of T.arjuna (250 and 500 mg/kg body weight) for 30 days showed significant (p<0.05) reduction in glucose.
The activities of glycolytic enzymes (hexokinase, aldolase, phosphoglucoisomerase) in the liver and kidney of control and experimental rats are shown in (Tables 2 and 3 ).
The activity of hexokinase and phosphoglucoisomerase were seen significantly decreased, where as the activity of aldolase was seen significantly increased in diabetic rats, when compared with control rats (p<0.05). Oral administration of T.arjuna (250 and 500 mg/kg body weight) for 30 days significantly reversed these values to normal.
The activities of gluconeogenic enzymes (glucose 6-phosphatase and fructose-1, 6-diphosphatase) in the liver and kidney of control and experimental animals are shown in (Tables 4 and 5 ).
The acitivity of gluconeogenic enzymes, glucose-6-phosphatase and fructose-1, 6-diphosphatase (liver and kidney) were found significantly elevated in diabetic rats when compared with control rats (p<0.05). Oral administration of T.arjuna (250 mg and 500 mg/kg body weight) for 30 days brought back the activity of the above enzymes to the near normal level. However, drug alone treated rats (250 and 500 mg/kg body weight) did not show any significant (p>0.05) changes when compared with control animals. In our study, administration of T.arjuna bark extract resulted in a significant reduction in blood glucose level, when compared with diabetic control animals. The extract containing 500 mg/kg body weight showed a better glucose level reduction than 250 mg/kg body weight. The mechanism may be through the stimulation of bcell for elevated secretion of insulin, there by increasing the utilization of glucose in various tissues (27) .
Liver functions as a "glucostat" and plays a vital role in the maintenance of blood glucose level and hence it is of interest to examine the possible role of T.arjuna on key enzymes of carbohydrate metabolism in liver. Liver is the candidate organ involved in glucose homeostasis. It is the main site for glycolysis, a process where glucose is degraded and gluconeogenesis, where glucose is synthesized from lactate, amino acids and glycerol. These are the two important complementary events that balance the glucose load in our body (28) .
Hexokinase is the prime enzyme catalysing glucose phosphorylation. The first step in glycolysis (29) is severely impaired during diabetes (30) . Impairment of hexokinase activity suggest the impaired oxidation of glucose via glycolysis Insulin influences the intracellular utilization of glucose in a number of ways. Insulin increases hepatic glycolysis by increasing the activity and amount of several key enzymes including glucokinase and phosphofructokinase. Hexokinase is universally present in cells of all types. Hexokinase catalyses the conversion of glucose to glucose 6-phosphate and plays a central role in the maintenance of glucose homeostasis. In the liver, this above enzyme is an important regulator of glucose storage and disposal (31).
The hexokinase activity was found to be decreased in diabetic rats which may be due to insulin deficiency (insulin stimulates and activates hexokinase). Treatment with T.arjuna elevated the activity of hexokinase in the liver. T.arjuna may stimulate insulin secretion, which may activate hexokinase, there by increasing utilization of glucose leading to decreased blood sugar levels.
Activity of phosphoglucoisomerase and ATP dependent phosphofructokinase enzyme are reported to be under regulation by citrate (32) , which is a TCA cycle intermediate. Decrease in activity of phosphoglucoisomerase might be expected to inhibit the proportion of glucose 6-phosphate metabolized via the glycolytic pathway. (33) .
Aldolase, another key enzyme in the glycolytic pathway, increases in diabetes and this may be due to cell impairment and necrosis (34) . In experimental diabetes the cells are subjected to alloxan induced-damage and very often exhibit glycolysis after a period of increased oxygen uptake. Fructose-1,6-diphosphatase and glucose-6-phosphatase are important regulatory enzymes in gluconeogenesis. In diabetic animals the enzyme levels were observed to increase (34) . The increased activities of glucose 6-phosphatase and fructose-1,6-diphosphatase in liver and kidney of the alloxan induced diabetic rats may be due to insulin insufficiency.
Insulin decreases gluconeogenesis by decreasing the activities of key enzymes, such as glucose-6-phosphatase, fructose-1, 6-diphosphatase, phosphoenolpyruvate carboxykinase and pyruvate carboxylase (35) . In Terminalia treated rats, these two enzymes (glucose-6-phosphatase, fructose-1,6-diphosphatase) were seen significantly reduced in liver and kidney. This may be due to increased insulin secretion, which is responsible for the repression of the gluconeogenic key enzymes.
From the present study, it is concluded that T.arjuna bark extract exhibited antidiabetic activity by enhancing the peripheral utilization of glucose by correcting the impaired liver and kidney glycolysis and by limiting its gluconeogenic formation similar to insulin. This effect may be due to the presence of tannin, saponin, flavonoids and other constituents presence in the bark, which could act synergistically or independently in enhancing the activity of glycolytic and gluconeogenic enzymes.
